ALB Stock Forecast 2025-2026
Distance to ALB Price Targets
ALB Price Momentum
10 Quality Stocks Worth Considering Now
Researching Albemarle (ALB) after the drop? Our ex-Goldman Sachs analyst reveals if it made our list of 10 oversold quality stocks with strong growth potential.
Get our FREE market selloff report + exclusive analysis on ALB and similar high-potential opportunities.
Latest ALB Stock Price Targets & Analyst Predictions
Based on our analysis of 35 Wall Street analysts, ALB has a neutral consensus with a median price target of $86.50 (ranging from $60.00 to $225.00). The overall analyst rating is Buy (6.9/10). Currently trading at $52.91, the median forecast implies a 63.5% upside. This outlook is supported by 9 Buy, 17 Hold, and 2 Sell ratings.
The most optimistic forecast comes from Joshua Spector at UBS, projecting a 325.3% upside. Conversely, the most conservative target is provided by Ben Kallo at Baird, suggesting a 13.4% upside.
Please note that analyst price targets are forward-looking estimates subject to substantial market, economic, and company-specific risks. Past performance does not guarantee future results, and actual stock performance may materially differ from these projections. Investors should conduct their own due diligence and consider their investment objectives and risk tolerance before making investment decisions.
ALB Analyst Ratings
ALB Price Target Range
Latest ALB Stock Forecasts by Analyst
These are the latest 20 analyst ratings and price targets for ALB.
Date | Firm | Analyst | Rating | Change | Price Target |
---|---|---|---|---|---|
Apr 15, 2025 | Citigroup | Patrick Cunningham | Neutral | Maintains | $64.00 |
Apr 15, 2025 | Baird | Ben Kallo | Neutral | Maintains | $60.00 |
Apr 14, 2025 | Keybanc | Bradley Thomas | Overweight | Maintains | $102.00 |
Apr 14, 2025 | Truist Securities | Peter Osterland | Hold | Maintains | $65.00 |
Apr 9, 2025 | Wells Fargo | Michael Sison | Equal-Weight | Maintains | $60.00 |
Apr 7, 2025 | UBS | Joshua Spector | Neutral | Maintains | $64.00 |
Mar 7, 2025 | Mizuho | John Roberts | Neutral | Maintains | $85.00 |
Feb 20, 2025 | Piper Sandler | Charles Neivert | Underweight | Maintains | $85.00 |
Feb 18, 2025 | Scotiabank | Ben Isaacson | Sector Perform | Maintains | $75.00 |
Feb 18, 2025 | Morgan Stanley | Vincent Andrews | Underweight | Maintains | $68.00 |
Feb 14, 2025 | Truist Securities | Peter Osterland | Hold | Maintains | $85.00 |
Feb 14, 2025 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $122.00 |
Feb 13, 2025 | UBS | Joshua Spector | Neutral | Maintains | $86.00 |
Jan 28, 2025 | Truist Securities | Peter Osterland | Hold | Initiates | $96.00 |
Jan 7, 2025 | Mizuho | John Roberts | Neutral | Maintains | $105.00 |
Dec 18, 2024 | Baird | Ben Kallo | Neutral | Maintains | $103.00 |
Nov 12, 2024 | RBC Capital | Arun Viswanathan | Outperform | Maintains | $133.00 |
Nov 12, 2024 | Keybanc | Aleksey Yefremov | Overweight | Maintains | $127.00 |
Nov 8, 2024 | Oppenheimer | Colin Rusch | Outperform | Maintains | $170.00 |
Oct 25, 2024 | Baird | Ben Kallo | Neutral | Maintains | $79.00 |
Albemarle Corporation (ALB) Competitors
The following stocks are similar to Albemarle based on their market capitalization and industry sector. These similar stocks potentially provide investors with alternative investment opportunities within the same market segment.
Albemarle Corporation (ALB) Financial Data
Albemarle Corporation has a market capitalization of $6.22B with a P/E ratio of 33.5x. The company generates $5.38B in trailing twelve-month revenue with a -21.9% profit margin.
Revenue growth is -47.7% quarter-over-quarter, while maintaining an operating margin of +1.8% and return on equity of -11.4%.
Valuation Metrics
Growth & Margins
Financial Health
Get All 10 Quality Stocks For This Market Selloff
Still researching investments after the market drop? Our ex-Goldman Sachs analyst has already identified the 10 highest-quality oversold stocks with strong fundamentals and upside potential.
Why spend hours researching when we've already done the work? Get instant access to our complete market selloff analysis.

Albemarle Corporation (ALB) Business Model
About Albemarle Corporation
Produces lithium, bromine, and catalysts for various industries.
Albemarle Corporation generates revenue by manufacturing and selling specialty chemicals, particularly lithium products that are crucial for battery production in electric vehicles. Their business model encompasses a diverse range of applications, including energy storage, petroleum refining, and pharmaceuticals, allowing them to leverage multiple market segments for growth.
Headquartered in Charlotte, North Carolina, Albemarle operates globally with strategically located production facilities and research centers. The company's focus on innovation and sustainability positions it as a key player in the transition to cleaner energy and advanced industrial processes, supported by strong partnerships and a robust supply chain.
Company Information
Sector
Basic Materials
Industry
Specialty Chemicals
Employees
8,300
CEO
Mr. Jerry Kent Masters Jr.
Country
United States
IPO Year
1994
Website
www.albemarle.comAlbemarle Corporation (ALB) Latest News & Analysis
The stock market sentiment gauge experiences fluctuations, leading to periods of both overly bullish and overly bearish sentiment.
Market sentiment can lead to volatility, impacting stock prices. Extreme bullishness or bearishness may signal potential corrections or opportunities for strategic buying or selling.
Albemarle (ALB) closed at $57.39, reflecting a 1.27% increase from its prior closing price.
Albemarle's 1.27% price increase indicates positive market sentiment, potentially attracting more buyers and suggesting confidence in the company's performance.
U.S. imports of critical minerals are being reported by CNBC, highlighting trends and developments in this essential sector for investors to monitor.
U.S. imports of critical minerals affect supply chains, impacting industries like tech and renewable energy. Changes can influence stock prices and investment strategies in these sectors.
Albemarle (ALB) is currently a focus for Zacks.com users, indicating heightened interest and potential developments worth monitoring for investors.
Increased attention from Zacks.com users may indicate heightened interest or potential volatility in Albemarle's stock, impacting trading strategies and investment decisions.
Albemarle (ALB) experienced significant trading volume recently; however, recent earnings estimate revisions may hinder further upward movement.
Albemarle's high trading volume signals heightened interest, but negative earnings estimate revisions could hinder short-term stock performance.
S&P 500 investors may face challenges due to rising tariffs, with some companies lacking earnings growth to rely on.
Rising tariffs could pressure profit margins, making earnings growth crucial. Companies lacking earnings growth may face heightened risks, impacting stock performance and investor sentiment.
Frequently Asked Questions About ALB Stock
What is Albemarle Corporation's (ALB) stock forecast for 2025?
Based on our analysis of 35 Wall Street analysts, Albemarle Corporation (ALB) has a median price target of $86.50. The highest price target is $225.00 and the lowest is $60.00.
Is ALB stock a good investment in 2025?
According to current analyst ratings, ALB has 9 Buy ratings, 17 Hold ratings, and 2 Sell ratings. The stock is currently trading at $52.91. Always conduct your own research and consider your investment goals before making investment decisions.
What is the long-term price prediction for ALB stock?
Wall Street analysts predict ALB stock could reach $86.50 in the next 12 months. This represents a 63.5% increase from the current price of $52.91. Please note that this is a projection by Wall Street analysts and not a guarantee.
What is Albemarle Corporation's business model?
Albemarle Corporation generates revenue by manufacturing and selling specialty chemicals, particularly lithium products that are crucial for battery production in electric vehicles. Their business model encompasses a diverse range of applications, including energy storage, petroleum refining, and pharmaceuticals, allowing them to leverage multiple market segments for growth.
What is the highest forecasted price for ALB Albemarle Corporation?
The highest price target for ALB is $225.00 from Joshua Spector at UBS, which represents a 325.3% increase from the current price of $52.91.
What is the lowest forecasted price for ALB Albemarle Corporation?
The lowest price target for ALB is $60.00 from Ben Kallo at Baird, which represents a 13.4% increase from the current price of $52.91.
What is the overall ALB consensus from analysts for Albemarle Corporation?
The overall analyst consensus for ALB is neutral. Out of 35 Wall Street analysts, 9 rate it as Buy, 17 as Hold, and 2 as Sell, with a median price target of $86.50.
How accurate are ALB stock price projections?
Stock price projections, including those for Albemarle Corporation, are based on various factors including financial models, market conditions, and analyst forecasts. While these predictions provide valuable insights, they should be considered alongside your own research and risk tolerance.
Important Disclaimer
The information provided by Ticker Nerd is for educational and informational purposes only. It should not be considered financial or investment advice. Past performance is not indicative of future results. Always conduct your own research and consult with a qualified financial advisor before making any investment decisions. Analyst ratings and price forecasts are sourced from Wall St analysts and other experts. These projections are speculative and do not guarantee future stock performance.